Saturday, August 29, 2026
Home Tags Medical affairs

Tag: medical affairs

FDA SIUU guidance materials illustrating scientific information on unapproved uses and pharmaceutical communications with healthcare professionals.

Off-Label or On-Target? Inside Pharma’s New SIUU Playbook

Donna Pacheco -
0
Pharma professionals using spatial computing to explore an interactive 3D anatomical model at a medical congress.

The VR Booth Is Dead: Spatial Computing for Pharma Marketing

Donna Pacheco -
0
Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

Donna Pacheco -
0
Doctor reviewing clinical information on a smartphone while secure messaging icons represent private HCP dark social conversations and peer-to-peer medical communication.

The Dark Social Doctor: Pharma’s Biggest HCP Audience You Can’t See

Donna Pacheco -
0
Healthcare professional reviewing AI-generated medical insights as an artificial intelligence assistant analyzes pharmaceutical research and scientific content.

What Happens When AI Starts Reading Pharma Marketing Before Doctors Do?

Donna Pacheco -
0
Healthcare provider reviewing electronic health records with diagnostic coding data and digital patient analytics on a computer dashboard.

Decoding the Funnel: Why Better Diagnostic Coding May Be Pharma’s Next...

Donna Pacheco -
0
Laptop dissolving into digital assets at sunset beside pharmaceutical packaging, representing brand lifecycle operations and the responsible retirement of pharmaceutical digital ecosystems.

The Digital Sunset: How to Retire a Pharma Brand Without Leaving...

Donna Pacheco -
0
Healthcare professional comparing traditional Key Opinion Leaders with Digital Opinion Leaders using social media, podcasts, and online medical communities for pharmaceutical engagement.

DOLs vs. KOLs: Why Academic Credentials No Longer Guarantee Digital Influence

Donna Pacheco -
0
Physician reviewing patient treatment progression while evaluating second-line therapy options during a clinical care decision.

The Escalation Effect: Where Pharma’s Biggest Prescribing Decisions Really Happen

Donna Pacheco -
0
Doctor reviewing AI-generated synthetic control arm clinical trial data on a transparent digital interface to evaluate evidence for pharmaceutical decision-making.

The In-Silico Sell: Can Pharma Convince Doctors to Trust AI-Generated Clinical...

Donna Pacheco -
0
12Page 1 of 2
- Advertisement -

EDITOR PICKS

POPULAR POSTS

RECENT POSTS

POPULAR CATEGORY

© 2026. Pharma Marketing Network. All rights reserved.